Published in AIDS Weekly, May 9th, 2005
In a paper in PLoS Medicine, a worldwide collaboration of HIV researchers looked at the mutations found in more than 3000 people infected with non-subtype-B HIV-1 - the most common HIV-1 subtype globally. They compared the mutations with those found in over 4500 people with subtype B infections - the most common in the developed world and the subtype that most HIV drugs have been targeted against.
Reassuringly, they found few novel mutations in non-subtype-B viruses exposed to the current antiretroviral drugs and concluded that the present focus on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.